Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $1.57 billion. The enterprise value is $1.18 billion.
| Market Cap | 1.57B |
| Enterprise Value | 1.18B |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 140.36 million shares outstanding. The number of shares has increased by 21.22% in one year.
| Current Share Class | 140.36M |
| Shares Outstanding | 140.36M |
| Shares Change (YoY) | +21.22% |
| Shares Change (QoQ) | +5.02% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 99.92% |
| Float | 134.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.64 |
| Forward PS | 22.74 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 22.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.38.
| Current Ratio | 6.31 |
| Quick Ratio | 6.00 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -714.97 |
Financial Efficiency
Return on equity (ROE) is -62.60% and return on invested capital (ROIC) is -32.32%.
| Return on Equity (ROE) | -62.60% |
| Return on Assets (ROA) | -29.87% |
| Return on Invested Capital (ROIC) | -32.32% |
| Return on Capital Employed (ROCE) | -53.13% |
| Weighted Average Cost of Capital (WACC) | 12.47% |
| Revenue Per Employee | $140,284 |
| Profits Per Employee | -$1.13M |
| Employee Count | 377 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.23% in the last 52 weeks. The beta is 1.82, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 1.82 |
| 52-Week Price Change | +17.23% |
| 50-Day Moving Average | 12.05 |
| 200-Day Moving Average | 13.01 |
| Relative Strength Index (RSI) | 44.46 |
| Average Volume (20 Days) | 4,355,134 |
Short Selling Information
The latest short interest is 44.44 million, so 31.66% of the outstanding shares have been sold short.
| Short Interest | 44.44M |
| Short Previous Month | 45.11M |
| Short % of Shares Out | 31.66% |
| Short % of Float | 33.05% |
| Short Ratio (days to cover) | 7.63 |
Income Statement
In the last 12 months, NTLA had revenue of $52.89 million and -$426.14 million in losses. Loss per share was -$3.35.
| Revenue | 52.89M |
| Gross Profit | -218.03M |
| Operating Income | -436.85M |
| Pretax Income | -426.14M |
| Net Income | -426.14M |
| EBITDA | -428.26M |
| EBIT | -436.85M |
| Loss Per Share | -$3.35 |
Balance Sheet
The company has $474.11 million in cash and $230.14 million in debt, with a net cash position of $384.66 million or $2.74 per share.
| Cash & Cash Equivalents | 474.11M |
| Total Debt | 230.14M |
| Net Cash | 384.66M |
| Net Cash Per Share | $2.74 |
| Equity (Book Value) | 613.09M |
| Book Value Per Share | 4.37 |
| Working Capital | 426.04M |
Cash Flow
In the last 12 months, operating cash flow was -$355.17 million and capital expenditures -$2.90 million, giving a free cash flow of -$358.08 million.
| Operating Cash Flow | -355.17M |
| Capital Expenditures | -2.90M |
| Depreciation & Amortization | 8.59M |
| Net Borrowing | 73.76M |
| Free Cash Flow | -358.08M |
| FCF Per Share | -$2.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | -826.00% |
| Pretax Margin | -805.75% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.22% |
| Shareholder Yield | -21.22% |
| Earnings Yield | -30.04% |
| FCF Yield | -22.84% |
Analyst Forecast
The average price target for NTLA is $22.78, which is 104.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.78 |
| Price Target Difference | 104.12% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 87.56% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of -2.07 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.07 |
| Piotroski F-Score | 4 |